UK markets close in 1 hour 58 minutes
  • FTSE 100

    7,008.64
    -10.89 (-0.16%)
     
  • FTSE 250

    22,547.68
    +25.50 (+0.11%)
     
  • AIM

    1,255.62
    +1.37 (+0.11%)
     
  • GBP/EUR

    1.1602
    +0.0062 (+0.54%)
     
  • GBP/USD

    1.3958
    +0.0118 (+0.85%)
     
  • BTC-GBP

    40,386.12
    +1,393.56 (+3.57%)
     
  • CMC Crypto 200

    1,275.18
    -23.77 (-1.83%)
     
  • S&P 500

    4,179.21
    -6.26 (-0.15%)
     
  • DOW

    34,118.85
    -81.82 (-0.24%)
     
  • CRUDE OIL

    63.15
    +0.02 (+0.03%)
     
  • GOLD FUTURES

    1,767.70
    -12.50 (-0.70%)
     
  • NIKKEI 225

    29,685.37
    +2.00 (+0.01%)
     
  • HANG SENG

    29,106.15
    +136.44 (+0.47%)
     
  • DAX

    15,434.60
    -25.15 (-0.16%)
     
  • CAC 40

    6,312.83
    +25.76 (+0.41%)
     

Global 3D TVs Market to Reach $627.5 Billion by 2027

ReportLinker
·12-min read

Abstract: - Global 3D TVs Market to Reach $627. 5 Billion by 2027. - Amid the COVID-19 crisis, the global market for 3D TVs estimated at US$102. 2 Billion in the year 2020, is projected to reach a revised size of US$627.

New York, April 07, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global 3D TVs Industry" - https://www.reportlinker.com/p05818142/?utm_source=GNW
5 Billion by 2027, growing at aCAGR of 29.6% over the period 2020-2027. Active 3D TV, one of the segments analyzed in the report, is projected to record 31.6% CAGR and reach US$450.1 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Passive 3D TV segment is readjusted to a revised 25.3% CAGR for the next 7-year period.
- The U.S. Market is Estimated at $27.4 Billion, While China is Forecast to Grow at 36.7% CAGR
- The 3D TVs market in the U.S. is estimated at US$27.4 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$165 Billion by the year 2027 trailing a CAGR of 37% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 23.4% and 27% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 25.3% CAGR.

- Select Competitors (Total 32 Featured) -

  • Canon, Inc.

  • FUJIFILM Holdings Corporation

  • LG Electronics, Inc.

  • Samsung Electronics America, Inc.

  • Sharp Corporation

  • Sony India Pvt., Ltd.




Read the full report: https://www.reportlinker.com/p05818142/?utm_source=GNW

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE
Table 1: World Current & Future Analysis for Zygomatic and
Pterygoid Implants by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR

Table 2: World Historic Review for Zygomatic and Pterygoid
Implants by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR

Table 3: World 15-Year Perspective for Zygomatic and Pterygoid
Implants by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets for Years 2012, 2020 & 2027

Table 4: World Current & Future Analysis for Severe Atrophy of
Maxillary Bone by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR

Table 5: World Historic Review for Severe Atrophy of Maxillary
Bone by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 6: World 15-Year Perspective for Severe Atrophy of
Maxillary Bone by Geographic Region - Percentage Breakdown of
Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific
and Rest of World for Years 2012, 2020 & 2027

Table 7: World Current & Future Analysis for Maxillary sinuses
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2020 through 2027 and
% CAGR

Table 8: World Historic Review for Maxillary sinuses by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 9: World 15-Year Perspective for Maxillary sinuses by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2020 & 2027

Table 10: World Current & Future Analysis for Other
Applications by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2020 through
2027 and % CAGR

Table 11: World Historic Review for Other Applications by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 12: World 15-Year Perspective for Other Applications by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2020 & 2027

III. MARKET ANALYSIS

UNITED STATES
Table 13: USA Current & Future Analysis for Zygomatic and
Pterygoid Implants by Application - Severe Atrophy of Maxillary
Bone, Maxillary sinuses and Other Applications - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 14: USA Historic Review for Zygomatic and Pterygoid
Implants by Application - Severe Atrophy of Maxillary Bone,
Maxillary sinuses and Other Applications Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR

Table 15: USA 15-Year Perspective for Zygomatic and Pterygoid
Implants by Application - Percentage Breakdown of Value Sales
for Severe Atrophy of Maxillary Bone, Maxillary sinuses and
Other Applications for the Years 2012, 2020 & 2027

CANADA
Table 16: Canada Current & Future Analysis for Zygomatic and
Pterygoid Implants by Application - Severe Atrophy of Maxillary
Bone, Maxillary sinuses and Other Applications - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 17: Canada Historic Review for Zygomatic and Pterygoid
Implants by Application - Severe Atrophy of Maxillary Bone,
Maxillary sinuses and Other Applications Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR

Table 18: Canada 15-Year Perspective for Zygomatic and
Pterygoid Implants by Application - Percentage Breakdown of
Value Sales for Severe Atrophy of Maxillary Bone, Maxillary
sinuses and Other Applications for the Years 2012, 2020 & 2027

JAPAN
Table 19: Japan Current & Future Analysis for Zygomatic and
Pterygoid Implants by Application - Severe Atrophy of Maxillary
Bone, Maxillary sinuses and Other Applications - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 20: Japan Historic Review for Zygomatic and Pterygoid
Implants by Application - Severe Atrophy of Maxillary Bone,
Maxillary sinuses and Other Applications Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR

Table 21: Japan 15-Year Perspective for Zygomatic and Pterygoid
Implants by Application - Percentage Breakdown of Value Sales
for Severe Atrophy of Maxillary Bone, Maxillary sinuses and
Other Applications for the Years 2012, 2020 & 2027

CHINA
Table 22: China Current & Future Analysis for Zygomatic and
Pterygoid Implants by Application - Severe Atrophy of Maxillary
Bone, Maxillary sinuses and Other Applications - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 23: China Historic Review for Zygomatic and Pterygoid
Implants by Application - Severe Atrophy of Maxillary Bone,
Maxillary sinuses and Other Applications Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR

Table 24: China 15-Year Perspective for Zygomatic and Pterygoid
Implants by Application - Percentage Breakdown of Value Sales
for Severe Atrophy of Maxillary Bone, Maxillary sinuses and
Other Applications for the Years 2012, 2020 & 2027

EUROPE
Table 25: Europe Current & Future Analysis for Zygomatic and
Pterygoid Implants by Geographic Region - France, Germany,
Italy, UK and Rest of Europe Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2020 through 2027 and %
CAGR

Table 26: Europe Historic Review for Zygomatic and Pterygoid
Implants by Geographic Region - France, Germany, Italy, UK and
Rest of Europe Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 27: Europe 15-Year Perspective for Zygomatic and
Pterygoid Implants by Geographic Region - Percentage Breakdown
of Value Sales for France, Germany, Italy, UK and Rest of
Europe Markets for Years 2012, 2020 & 2027

Table 28: Europe Current & Future Analysis for Zygomatic and
Pterygoid Implants by Application - Severe Atrophy of Maxillary
Bone, Maxillary sinuses and Other Applications - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 29: Europe Historic Review for Zygomatic and Pterygoid
Implants by Application - Severe Atrophy of Maxillary Bone,
Maxillary sinuses and Other Applications Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR

Table 30: Europe 15-Year Perspective for Zygomatic and
Pterygoid Implants by Application - Percentage Breakdown of
Value Sales for Severe Atrophy of Maxillary Bone, Maxillary
sinuses and Other Applications for the Years 2012, 2020 & 2027

FRANCE
Table 31: France Current & Future Analysis for Zygomatic and
Pterygoid Implants by Application - Severe Atrophy of Maxillary
Bone, Maxillary sinuses and Other Applications - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 32: France Historic Review for Zygomatic and Pterygoid
Implants by Application - Severe Atrophy of Maxillary Bone,
Maxillary sinuses and Other Applications Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR

Table 33: France 15-Year Perspective for Zygomatic and
Pterygoid Implants by Application - Percentage Breakdown of
Value Sales for Severe Atrophy of Maxillary Bone, Maxillary
sinuses and Other Applications for the Years 2012, 2020 & 2027

GERMANY
Table 34: Germany Current & Future Analysis for Zygomatic and
Pterygoid Implants by Application - Severe Atrophy of Maxillary
Bone, Maxillary sinuses and Other Applications - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 35: Germany Historic Review for Zygomatic and Pterygoid
Implants by Application - Severe Atrophy of Maxillary Bone,
Maxillary sinuses and Other Applications Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR

Table 36: Germany 15-Year Perspective for Zygomatic and
Pterygoid Implants by Application - Percentage Breakdown of
Value Sales for Severe Atrophy of Maxillary Bone, Maxillary
sinuses and Other Applications for the Years 2012, 2020 & 2027

ITALY
Table 37: Italy Current & Future Analysis for Zygomatic and
Pterygoid Implants by Application - Severe Atrophy of Maxillary
Bone, Maxillary sinuses and Other Applications - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 38: Italy Historic Review for Zygomatic and Pterygoid
Implants by Application - Severe Atrophy of Maxillary Bone,
Maxillary sinuses and Other Applications Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR

Table 39: Italy 15-Year Perspective for Zygomatic and Pterygoid
Implants by Application - Percentage Breakdown of Value Sales
for Severe Atrophy of Maxillary Bone, Maxillary sinuses and
Other Applications for the Years 2012, 2020 & 2027

UNITED KINGDOM
Table 40: UK Current & Future Analysis for Zygomatic and
Pterygoid Implants by Application - Severe Atrophy of Maxillary
Bone, Maxillary sinuses and Other Applications - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 41: UK Historic Review for Zygomatic and Pterygoid
Implants by Application - Severe Atrophy of Maxillary Bone,
Maxillary sinuses and Other Applications Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR

Table 42: UK 15-Year Perspective for Zygomatic and Pterygoid
Implants by Application - Percentage Breakdown of Value Sales
for Severe Atrophy of Maxillary Bone, Maxillary sinuses and
Other Applications for the Years 2012, 2020 & 2027

REST OF EUROPE
Table 43: Rest of Europe Current & Future Analysis for
Zygomatic and Pterygoid Implants by Application - Severe
Atrophy of Maxillary Bone, Maxillary sinuses and Other
Applications - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 44: Rest of Europe Historic Review for Zygomatic and
Pterygoid Implants by Application - Severe Atrophy of Maxillary
Bone, Maxillary sinuses and Other Applications Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 45: Rest of Europe 15-Year Perspective for Zygomatic and
Pterygoid Implants by Application - Percentage Breakdown of
Value Sales for Severe Atrophy of Maxillary Bone, Maxillary
sinuses and Other Applications for the Years 2012, 2020 & 2027

ASIA-PACIFIC
Table 46: Asia-Pacific Current & Future Analysis for Zygomatic
and Pterygoid Implants by Application - Severe Atrophy of
Maxillary Bone, Maxillary sinuses and Other Applications -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 47: Asia-Pacific Historic Review for Zygomatic and
Pterygoid Implants by Application - Severe Atrophy of Maxillary
Bone, Maxillary sinuses and Other Applications Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 48: Asia-Pacific 15-Year Perspective for Zygomatic and
Pterygoid Implants by Application - Percentage Breakdown of
Value Sales for Severe Atrophy of Maxillary Bone, Maxillary
sinuses and Other Applications for the Years 2012, 2020 & 2027

REST OF WORLD
Table 49: Rest of World Current & Future Analysis for Zygomatic
and Pterygoid Implants by Application - Severe Atrophy of
Maxillary Bone, Maxillary sinuses and Other Applications -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 50: Rest of World Historic Review for Zygomatic and
Pterygoid Implants by Application - Severe Atrophy of Maxillary
Bone, Maxillary sinuses and Other Applications Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 51: Rest of World 15-Year Perspective for Zygomatic and
Pterygoid Implants by Application - Percentage Breakdown of
Value Sales for Severe Atrophy of Maxillary Bone, Maxillary
sinuses and Other Applications for the Years 2012, 2020 & 2027

IV. COMPETITION
Total Companies Profiled: 44
Read the full report: https://www.reportlinker.com/p05818142/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001